Welcome to the Veterinary Cancer Trials website. This site is sponsored by the Veterinary Cooperative Oncology Group (VCOG), a group of board-certified veterinary oncologists and associated specialists assembled to promote high quality veterinary oncology collaborative investigations through the establishment of common goals and endpoints for the purpose of benefitting both animals and people affected by cancer. VCOG represents the collective knowledge of the specialty of veterinary oncology.
This site was designed for use by everyone who participates in the treatment of pet animals with cancer, including pet owners, general practice veterinarians, and oncologists and other specialty veterinarians. Information is provided to inform both private practice and academic veterinarians, and to promote accrual for the timely completion of clinical trials while providing state-of-the-art treatment options for pets with cancer.
To use this site, you may simply click the box for searching for trials based on specific criteria (type of cancer, geographic location of clinical trial, or species of animal), or you can browse all trials. Each trial description provides basic information needed to determine whether a pet is eligible for a trial, what a trial entails, and an appropriate contact person if there is a trial of interest. Information is updated at least monthly.
If you are a designated contact for an institution that initiates clinical trials, you can log in as instructed. This will allow you to enter, edit, or remove only trials from your institution. If you are a member of the Veterinary Cancer Society, you will be able to log in using your VCS website login information. This will allow you to view information that is not displayed for the general public such as details of trial design. You will not be able to modify any trial data for any institution.
Thank you for visiting this site. Our goal is to promote cutting edge therapy of pets with cancer and facilitate timely completion of clinical trials so that promising new therapies can enter clinical practice sooner.
For questions related to this site, please contact email@example.com